BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28572268)

  • 21. Can progress in reducing alcohol-impaired driving fatalities be resumed? Results of a workshop sponsored by the Transportation Research Board, Alcohol, Other Drugs, and Transportation Committee (ANB50).
    Fell JC; Beirness DJ; Voas RB; Smith GS; Jonah B; Maxwell JC; Price J; Hedlund J
    Traffic Inj Prev; 2016 Nov; 17(8):771-81. PubMed ID: 26980557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enforcement uniquely predicts reductions in alcohol-impaired crash fatalities.
    Yao J; Johnson MB; Tippetts S
    Addiction; 2016 Mar; 111(3):448-53. PubMed ID: 26451697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Alcohol and Cannabis Among Adults Driving Children in Washington State.
    Romano E; Kelley-Baker T; Hoff S; Eichelberger A; Ramírez A
    J Stud Alcohol Drugs; 2019 Mar; 80(2):196-200. PubMed ID: 31014464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The problem of suspended and revoked drivers who avoid detection at checkpoints.
    Parrish KE; Masten SV
    Traffic Inj Prev; 2015; 16(2):97-103. PubMed ID: 24730601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicological oral fluid results among Spanish drivers testing positive on on-site drug controls from 2013 to 2015.
    Lema-Atán JÁ; de Castro A; Lendoiro E; López-Rivadulla M; Cruz A
    Drug Alcohol Depend; 2019 Feb; 195():106-113. PubMed ID: 30611978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioids in oral fluid of Spanish drivers.
    Herrera-Gómez F; García-Mingo M; Colás M; González-Luque JC; Álvarez FJ
    Drug Alcohol Depend; 2018 Jun; 187():35-39. PubMed ID: 29626744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marijuana use and driving in Washington State: Risk perceptions and behaviors before and after implementation of retail sales.
    Eichelberger AH
    Traffic Inj Prev; 2019; 20(1):23-29. PubMed ID: 30822133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Victorian legislative framework for the random testing drivers at the roadside for the presence of illicit drugs: an evaluation of the characteristics of drivers detected from 2004 to 2006.
    Boorman M; Owens K
    Traffic Inj Prev; 2009 Mar; 10(1):16-22. PubMed ID: 19214873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis and psychomotor performance: a rational review of the evidence and implications for public policy.
    Armentano P
    Drug Test Anal; 2013 Jan; 5(1):52-6. PubMed ID: 22972702
    [No Abstract]   [Full Text] [Related]  

  • 31. Approaches for reducing alcohol-impaired driving: Evidence-based legislation, law enforcement strategies, sanctions, and alcohol-control policies.
    Fell JC
    Forensic Sci Rev; 2019 Jul; 31(2):161-184. PubMed ID: 31270060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between self-report of cannabis use and toxicological detection of THC/THCCOOH in blood and THC in oral fluid in drivers in a roadside survey.
    Van der Linden T; Silverans P; Verstraete AG
    Drug Test Anal; 2014; 6(1-2):137-42. PubMed ID: 23939912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Maryland's state police impaired driving reduction effort (SPIDRE).
    Beck KH; Fell JC; Kerns TJ
    Traffic Inj Prev; 2018 May; 19(4):339-344. PubMed ID: 29252001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
    Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
    Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the use and benefit of passive alcohol sensors during routine traffic stops.
    Fell JC; Compton C
    Annu Proc Assoc Adv Automot Med; 2007; 51():437-48. PubMed ID: 18184506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drivers who tested positive for cannabis in oral fluid: a longitudinal analysis of administrative data for Spain between 2011 and 2016.
    Herrera-Gómez F; García-Mingo M; Colás M; González-Luque JC; Alvarez FJ
    BMJ Open; 2019 Aug; 9(8):e026648. PubMed ID: 31455697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of impaired-driving enforcement intensity to drinking and driving on the roads.
    Fell JC; Waehrer G; Voas RB; Auld-Owens A; Carr K; Pell K
    Alcohol Clin Exp Res; 2015 Jan; 39(1):84-92. PubMed ID: 25515820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are oral fluid testing devices effective for the roadside detection of recent cannabis use? A systematic review.
    Dobri SCD; Moslehi AH; Davies TC
    Public Health; 2019 Jun; 171():57-65. PubMed ID: 31102828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roadside survey of alcohol and drug use among Norwegian drivers in 2016-2017: A follow-up of the 2008-2009 survey.
    Furuhaugen H; Jamt REG; Nilsson G; Vindenes V; Gjerde H
    Traffic Inj Prev; 2018; 19(6):555-562. PubMed ID: 29927625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DUID prevalence in Colorado's DUI citations.
    Wood E; Salomonsen-Sautel S
    J Safety Res; 2016 Jun; 57():33-8. PubMed ID: 27178077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.